UROLOGICAL MALIGNANCY DIAGNOSIS BY USING STANDARD PROTOCOL OF INVESTIGATION FOR HAEMATURIA
DOI:
https://doi.org/10.52206/jsmc.2011.1.1.31-35Abstract
OBJECTIVE: To diagnose the urological malignancy by using standard protocol of investigation for
Haematuria.
Materials and Methods: This prospective study was conducted in the Department of surgery Saidu
Teaching Hospital Swat from Jan 2005 to Dec 2008. The Standard protocol of investigating haematuria
included flexible cyctoscopy, urine cytology and culture, upper renal trac: imaging, consisting of renal tract
ultrasound scan, radiograph of Kidney, Ureter , Bladder (KUB) and intravenous urogram (IVU) in patients
where needed.
RESULTS: total of 455 patients were included in this study; 330 (72.52%) were males and 125 (27.47%)
were females. Frank Haematuria was reported by 155 (34%) patients.(110 males and 45 females). Patients
presenting with microscopic haematuria formed 65.93% (n=300) of the total (220 males and 80 females).
Median age was 55 years (20- 90). Malignancy was found in 12.52 % (n=57) of all patients 10.76% (n=49)
with frank haematuria and 1.75 % (n=8) of patients with microscopic haematuria.
No malignancy was detected under the age of 50 years with microscopic haematuria. Where 2.58% (n=4)
under 50 yearswith frank haematuria werediagnosed to have malignancy.
CONCLUSIONS: All patients with frank haematuria and those with microscopic haematuria above 50
years of age should be fully investigated to rule out urological malignancy. Patients under 50 years of age
with microscopic haematuria have a lower priority for investigation.
Keywords; haematuria, malignancy, intravenous urogram (IVU)
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2021 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.



